Transabdominal contrast-enhanced ultrasonography of pancreatic cancer

Pancreatology

Volumn 11, Issue SUPPL. 2, 2011, Pages 20-27

  Kersting, Stephan ^a   Roth, Johanna ^a   Bunk, Alfred ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Contrast enhanced ultrasonography; Cystic pancreatic lesions; Pancreatic ductal adenocarcinomas; Pseudocysts; Ultrasonography

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HUMAN; INTERMETHOD COMPARISON; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DISEASE; PANCREAS PSEUDOCYST; PANCREAS TUMOR; PANCREATITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID TUMOR; TRANSABDOMINAL CONTRAST ENHANCED ULTRASONOGRAPHY; TUMOR VOLUME;

EID: 79953833079     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000323480     Document Type: Article

References (54)

1. Bardeesy N, DePinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2002; 2:897-909. (Pubitemid 37328891)
2. Kuwahara K, Sasaki T, Kuwada Y, Murakami M, Yamasaki S, Chayama K: Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 2003;26:344-349. (Pubitemid 36529959)
3. Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, Greiner L, Jager K, Jong ND, Leen E, Lencioni R, Lindsell D, Martegani A, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T, EFSUMB Study Group: Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004;25:249-256. (Pubitemid 39128145)
4. D'Onofrio M, Megibow AJ, Faccioli N, Malago R, Capelli P, Falconi M, Mucelli RP: Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. AJR Am J Roentgenol 2007;189:1435-1442. (Pubitemid 350174806)
5. D'Onofrio M, Zamboni G, Faccioli N, Capelli P, Pozzi Mucelli R: Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 2007;32:171-181.
6. Itoh T, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K, Kanamori A, Ohmiya N, Niwa Y, Goto H: Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2005;100:144-152. (Pubitemid 41623282)
7. Oshikawa O, Tanaka S, Ioka T, Nakaizumi A, Hamada Y, Mitani T: Dynamic sonography of pancreatic tumors: Comparison with dynamic CT. AJR Am J Roentgenol 2002;178: 1133-1137. (Pubitemid 34411407)
8. Ozawa Y, Numata K, Tanaka K, Ueno N, Kiba T, Hara K, Morimoto M, Sakaguchi T, Sekihara H, Kubota T, Shimada H, Nakatani Y: Contrast-enhanced sonography of small pancreatic mass lesions. J Ultrasound Med 2002;21:983-991. (Pubitemid 34988605)
9. Takeda K, Goto H, Hirooka Y, Itoh A, Hashimoto S, Niwa K, Hayakawa T: Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiol 2003;44:103-106.
10. Kitano M, Kudo M, Maekawa K, Suetomi Y, Sakamoto H, Fukuta N, Nakaoka R, Kawasaki T: Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 2004;53:854-859. (Pubitemid 38662136)
11. Kersting S, Konopke R, Kersting F, Volk A, Distler M, Bergert H, Saeger HD, Grutzmann R, Bunk A: Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology 2009;137:1903-1911.
12. Dietrich CF, Ignee A, Frey H: Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique. Z Gastroenterol 2005;43:1219-1223. (Pubitemid 41719249)
13. Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF: Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006;12:246-250. (Pubitemid 43336923)
14. Hocke M, Ignee A, Topalidis T, Stallmach A, Dietrich CF: Contrast-enhanced endosonographic Doppler spectrum analysis is helpful in discrimination between focal chronic pancreatitis and pancreatic cancer. Pancreas 2007;35:286-288. (Pubitemid 47482526)
15. Faccioli N, D'Onofrio M, Comai A, Cugini C: Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med 2007;112:810-820. (Pubitemid 350155015)
16. Piscaglia F, Bolondi L, Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents: The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32:1369-1375.
17. Takeshima K, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Ichikawa H, Kawachi T, Ogawa S: Comparison of IV contrast-enhanced sonography and histopathology of pancreatic cancer. AJR Am J Roentgenol 2005;185:1193-1200.
18. Faccioli N, D'Onofrio M, Malago R, Zamboni G, Falconi M, Capelli P, Mucelli RP: Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas 2008;37: 265-268.
19. D'Onofrio M, Malago R, Zamboni G, Vasori S, Falconi M, Capelli P, Mansueto G: Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 2005;5:398-402. (Pubitemid 41160277)
20. D'Onofrio M, Zamboni G, Tognolini A, Malago R, Faccioli N, Frulloni L, Pozzi Mucelli R: Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 2006;12:4181-4184. (Pubitemid 44376898)
21. Kim T, Murakami T, Takamura M, Hori M, Takahashi S, Nakamori S, Sakon M, Tanji Y, Wakasa K, Nakamura H: Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 2001;177: 367-371. (Pubitemid 32660496)
22. Hermanek P: Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 1991;17:167-172.
23. Konopke R, Kersting S, Bergert H, Bloomenthal A, Gastmeier J, Saeger HD, Bunk A: Contrast-enhanced ultrasonography to detect liver metastases: a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007;22:201-207.
24. D'Onofrio M, Mansueto G, Falconi M, Procacci C: Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 2004;29:246-258. (Pubitemid 38365018)
25. Malago R, D'Onofrio M, Zamboni GA, Faccioli N, Falconi M, Boninsegna L, Mucelli RP: Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. AJR Am J Roentgenol 2009;192:424-430.
26. Dietrich CF: Comments and illustrations regarding the guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) - update 2008. Ultraschall Med 2008;29(suppl 4):S188-S202.
27. Sahani DV, Kadavigere R, Saokar A, Fernandez-del Castillo C, Brugge WR, Hahn PF: Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005;25:1471-1484. (Pubitemid 41695317)
28. Fugazzola C, Procacci C, Bergamo Andreis IA, Iacono C, Portuese A, Dompieri P, Laveneziana S, Zampieri PG, Jannucci A, Serio G, et al: Cystic tumors of the pancreas: evaluation by ultrasonography and computed tomography. Gastrointest Radiol 1991;16: 53-61.
29. D'Onofrio M, Caffarri S, Zamboni G, Falconi M, Mansueto G: Contrast-enhanced ultrasonography in the characterization of pancreatic mucinous cystadenoma. J Ultrasound Med 2004;23:1125-1129. (Pubitemid 39014791)
30. Procacci C, Carbognin G, Biasiutti C, Guarise A, Ghirardi C, Schenal G: Intraductal papillary mucinous tumors of the pancreas: spectrum of CT and MR findings with pathologic correlation. Eur Radiol 2001;11: 1939-1951. (Pubitemid 32936896)
31. Goldstein HM, Neiman HL, Bookstein JJ: Angiographic evaluation of pancreatic disease. A further appraisal. Radiology 1974; 112:275-282.
32. Koito K, Namieno T, Nagakawa T, Morita K: Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles. AJR Am J Roentgenol 1997;169:1263-1267. (Pubitemid 27452481)
33. Adsay NV, Basturk O, Klimstra DS, Kloppel G: Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol 2004;21:260-267. (Pubitemid 41390071)
34. Yang EY, Joehl RJ, Talamonti MS: Cystic neoplasms of the pancreas. J Am Coll Surg 1994;179:747-757. (Pubitemid 24372263)
35. Miyata T, Tomiyama T, Tano S, Ueno N: Differential diagnosis of pancreatic tumor by contrast enhanced color Doppler ultrasonography (in Japanese). Nippon Rinsho 1998;56:1024-1029.
36. Schueller G, Schima W, Schueller-Weidekamm C, Weber M, Stift A, Gnant M, Prokesch R: Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast. Radiology 2006;241:441-448. (Pubitemid 44632890)
37. Schima W: MRI of the pancreas: tumors and tumor-simulating processes. Cancer Imaging 2006;6:199-203.
38. Rickes S, Unkrodt K, Ocran K, Neye H, Wermke W: Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy. Pancreas 2003;26:76-81. (Pubitemid 36020270)
39. Rickes S, Randhan W, Malfertheiner P: Differentiation of cystic pancreatic lesions by echo-enhanced sonography with pulse inversion imaging - presentation of case reports. Z Gastroenterol 2004;42:317-321. (Pubitemid 38713937)
40. Rickes S, Monkemuller K, Malfertheiner P: Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. JOP 2006;7:584-592. (Pubitemid 44768633)
41. D'Onofrio M, Malago R, Vecchiato F, Zamboni G, Testoni M, Falconi M, Capelli P, Mucelli RP: Contrast-enhanced ultrasonography of small solid pseudopapillary tumors of the pancreas: enhancement pattern and pathologic correlation of 2 cases. J Ultrasound Med 2005;24: 849-854. (Pubitemid 40734633)
42. Numata K, Ozawa Y, Kobayashi N, Kubota T, Shimada H, Nozawa A, Nakatani Y, Sugimori K, Matsuo K, Imada T, Tanaka K: Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol 2005;40:631-640. (Pubitemid 41038793)
43. Ohshima T, Yamaguchi T, Ishihara T, Yoshikawa M, Kobayashi A, Sakaue N, Baba T, Yamada S, Saisho H: Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 2004;28:335-343. (Pubitemid 38437335)
44. Kobayashi A, Yamaguchi T, Ishihara T, Tadenuma H, Nakamura K, Saisho H: Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut 2005;54:1047. (Pubitemid 40873925)
45. Masaki T, Ohkawa S, Amano A, Ueno M, Miyakawa K, Tarao K: Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 2005;103:1026-1035. (Pubitemid 40270080)
46. Nagase M, Furuse J, Ishii H, Yoshino M: Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 2003;22:789-795. (Pubitemid 36903966)
47. Hirooka Y, Goto H, Ito A, Hayakawa S, Watanabe Y, Ishiguro Y, Kojima S, Hayakawa T, Naitoh Y: Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 1998;93:632-635. (Pubitemid 29081017)
48. Sofuni A, Iijima H, Moriyasu F, Nakayama D, Shimizu M, Nakamura K, Itokawa F, Itoi T: Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 2005;40:518-525. (Pubitemid 40823288)
49. Foster FS, Burns PN, Simpson DH, Wilson SR, Christopher DA, Goertz DE: Ultrasound for the visualization and quantification of tumor microcirculation. Cancer Metastasis Rev 2000;19:131-138. (Pubitemid 32004702)
50. Cosgrove D, Eckersley R: Contrast-enhanced ultrasound: Basic physics and technology overview;in Lencioni R (ed): Enhancing the Role of Ultrasound with Contrast Agents. Milan, Springer, 2006, pp 3-14.
51. Thorelius L: Usefulness of contrast-enhanced ultrasound in the characterization of pancreatic and renal masses;in Albrecht T, Thorelius L, Solbiati L, Cova L, Frauscher F (eds): Contrast-Enhanced Ultrasound in Clinical Practice: Liver, Prostate, Pancreas, Kidney and Lymph Nodes. Milan, Springer, 2005, pp 23-35.
52. Becker D, Strobel D, Bernatik T, Hahn EG: Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001;53:784-789. (Pubitemid 33717254)
53. Rickes S, Unkrodt K, Neye H, Ocran KW, Wermke W: Differentiation of pancreatic tumors by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol 2002;37: 1313-1320. (Pubitemid 35305770)
54. Rickes S, Unkrodt K, Ocran K, Neye H, Lochs H, Wermke W: Evaluation of Doppler ultrasonography criteria for the differential diagnosis of pancreatic tumors (in German). Ultraschall Med 2000;21:253-258.